Winningham Rick E
SEC CIK 1302443 · EDGAR
BoughtSold
Most active insiders at TBPH, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Samaha Eli | 10% | — | $5.91M |
| 2 | BROSHY ERAN | Dir | — | $2.47M |
| 3 | Farnum Rhonda | SVP, COMM, MEDICAL AFFAIRS | — | $1.46M |
| 4 | Miller Aine | SVP, DEV, HEAD OF IRE OFFICE | — | — |
| 5 | Grimaud Brett A. | SVP, GEN COUNSEL AND Sec | — | — |
| 6 | Sawaf Aziz | SVP, CFO | — | — |
| 7 | GRAY SUSANNAH | Dir | — | — |
| 8 | O'Connor Donal | Dir | — | — |
| 9 | Smaldone Alsup Laurie | Dir | — | — |
| 10 | Winningham Rick E | CEO, Dir | — | — |
Transactions 56
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-09-24 20:27 | 2026-09-23 | TBPH | Theravance Biopharma, Inc. | Winningham Rick E | CEO, Dir | D - Sale to Iss | — | -1.61M | 0 | -100% | — |
| DMI | 2026-09-24 20:27 | 2026-09-23 | TBPH | Theravance Biopharma, Inc. | Winningham Rick E | CEO, Dir | D - Sale to Iss | — | -116.0K | 0 | -100% | — |
| M | 2026-09-02 17:06 | 2026-08-31 | JAZZ | Jazz Pharmaceuticals plc | Winningham Rick E | Dir | F - Tax | $241.42 | -1,706 | 9,466 | -15% | -$411.9K |
| 2026-08-24 18:09 | 2026-08-20 | TBPH | Theravance Biopharma, Inc. | Winningham Rick E | CEO, Dir | F - Tax | $16.95 | -20.0K | 1.61M | -1% | -$339.6K | |
| 2026-08-07 17:57 | 2026-08-05 | JAZZ | Jazz Pharmaceuticals plc | Winningham Rick E | Dir | A - Grant | $0.00 | +1,605 | 11.2K | +17% | $0 | |
| D | 2026-05-27 18:13 | 2026-05-22 | JAZZ | Jazz Pharmaceuticals plc | Winningham Rick E | Dir | M - OptEx | $138.08 | +3,415 | 12.3K | +38% | +$471.5K |
| D | 2026-05-27 18:13 | 2026-05-22 | JAZZ | Jazz Pharmaceuticals plc | Winningham Rick E | Dir | S - Sale+OE | $241.57 | -2,741 | 9,567 | -22% | -$662.1K |
| 2026-05-22 18:27 | 2026-05-20 | TBPH | Theravance Biopharma, Inc. | Winningham Rick E | CEO, Dir | F - Tax | $16.55 | -20.0K | 1.63M | -1% | -$331.6K | |
| 2026-04-03 18:10 | 2026-04-01 | TBPH | Theravance Biopharma, Inc. | Winningham Rick E | CEO, Dir | A - Grant | $0.00 | +75.0K | 1.65M | +5% | $0 | |
| 2026-02-24 | 2026-02-20 | TBPH | Theravance Biopharma, Inc. | Winningham Rick E | CEO, Dir | F - Tax | $19.66 | -75.0K | 1.58M | -5% | -$1.47M | |
| I | 2025-11-21 | 2025-11-19 | TBPH | Theravance Biopharma, Inc. | Winningham Rick E | CEO, Dir | G - Gift | $0.00 | +9,900 | 23.4K | +73% | $0 |
| 2025-11-21 | 2025-11-19 | TBPH | Theravance Biopharma, Inc. | Winningham Rick E | CEO, Dir | G - Gift | $0.00 | -9,900 | 1.71M | -0.6% | $0 | |
| 2025-11-21 | 2025-11-20 | TBPH | Theravance Biopharma, Inc. | Winningham Rick E | CEO, Dir | F - Tax | $17.90 | -56.8K | 1.65M | -3% | -$1.02M | |
| 2025-11-20 | 2025-11-18 | JAZZ | Jazz Pharmaceuticals plc | Winningham Rick E | Dir | S - Sale | $180.86 | -5,500 | 8,893 | -38% | -$994.7K | |
| 2025-08-22 | 2025-08-20 | TBPH | Theravance Biopharma, Inc. | Winningham Rick E | CEO, Dir | F - Tax | $13.39 | -15.4K | 1.72M | -0.9% | -$206.1K | |
| 2025-08-11 | 2025-08-08 | JAZZ | Jazz Pharmaceuticals plc | Winningham Rick E | Dir | F - Tax | $111.25 | -1,805 | 14.4K | -11% | -$200.8K | |
| 2025-08-11 | 2025-08-07 | JAZZ | Jazz Pharmaceuticals plc | Winningham Rick E | Dir | A - Grant | $0.00 | +3,507 | 16.2K | +28% | $0 | |
| 2025-06-25 | 2025-06-23 | TBPH | Theravance Biopharma, Inc. | Winningham Rick E | CEO, Dir | G - Gift | $0.00 | -20.0K | 1.73M | -1% | $0 | |
| I | 2025-06-17 | 2025-06-13 | TBPH | Theravance Biopharma, Inc. | Winningham Rick E | CEO, Dir | G - Gift | $0.00 | +9,600 | 13.5K | +246% | $0 |
| 2025-06-17 | 2025-06-13 | TBPH | Theravance Biopharma, Inc. | Winningham Rick E | CEO, Dir | G - Gift | $0.00 | -9,600 | 1.75M | -0.5% | $0 | |
| 2025-05-22 | 2025-05-20 | TBPH | Theravance Biopharma, Inc. | Winningham Rick E | CEO, Dir | F - Tax | $9.45 | -15.4K | 1.76M | -0.9% | -$145.2K | |
| 2025-03-04 | 2025-02-28 | TBPH | Theravance Biopharma, Inc. | Winningham Rick E | CEO, Dir | A - Grant | $9.35 | +2,178 | 1.78M | +0.1% | +$20.4K | |
| 2025-02-24 | 2025-02-20 | TBPH | Theravance Biopharma, Inc. | Winningham Rick E | CEO, Dir | F - Tax | $9.66 | -35.1K | 1.78M | -2% | -$339.3K | |
| 2024-11-22 | 2024-11-20 | TBPH | Theravance Biopharma, Inc. | Winningham Rick E | CEO, Dir | F - Tax | $9.97 | -16.0K | 1.81M | -0.9% | -$159.5K | |
| 2024-11-19 | 2024-11-14 | TBPH | Theravance Biopharma, Inc. | Winningham Rick E | CEO, Dir | A - Grant | $9.57 | +3,193 | 1.83M | +0.2% | +$30.6K | |
| 2024-08-22 | 2024-08-20 | TBPH | Theravance Biopharma, Inc. | Winningham Rick E | CEO, Dir | F - Tax | $8.22 | -16.0K | 1.82M | -0.9% | -$131.5K | |
| 2024-08-09 | 2024-08-07 | TBPH | Theravance Biopharma, Inc. | Winningham Rick E | CEO, Dir | A - Grant | $7.83 | +3,252 | 1.84M | +0.2% | +$25.5K | |
| 2024-08-06 | 2024-08-06 | JAZZ | Jazz Pharmaceuticals plc | Winningham Rick E | Dir | F - Tax | $111.35 | -1,484 | 12.7K | -10% | -$165.2K | |
| 2024-08-06 | 2024-08-02 | JAZZ | Jazz Pharmaceuticals plc | Winningham Rick E | Dir | A - Grant | $0.00 | +3,731 | 14.2K | +36% | $0 | |
| 2024-05-22 | 2024-05-20 | TBPH | Theravance Biopharma, Inc. | Winningham Rick E | CEO, Dir | F - Tax | $9.10 | -16.0K | 1.84M | -0.9% | -$145.6K | |
| 2024-05-17 | 2024-05-15 | TBPH | Theravance Biopharma, Inc. | Winningham Rick E | CEO, Dir | A - Grant | $9.85 | +2,068 | 1.85M | +0.1% | +$20.4K | |
| 2024-04-04 | 2024-04-02 | TBPH | Theravance Biopharma, Inc. | Winningham Rick E | CEO, Dir | A - Grant | $0.00 | +300.0K | 1.85M | +19% | $0 | |
| 2024-03-19 | 2024-03-15 | TBPH | Theravance Biopharma, Inc. | Winningham Rick E | CEO, Dir | A - Grant | $8.64 | +2,704 | 1.56M | +0.2% | +$23.4K | |
| I | 2024-03-19 | 2024-03-15 | TBPH | Theravance Biopharma, Inc. | Winningham Rick E | CEO, Dir | G - Gift | $0.00 | +3,900 | 3,900 | New | $0 |
| M | 2024-03-19 | 2024-03-15 | TBPH | Theravance Biopharma, Inc. | Winningham Rick E | CEO, Dir | G - Gift | $0.00 | -10.9K | 1.55M | -0.7% | $0 |
| 2024-02-22 | 2024-02-20 | TBPH | Theravance Biopharma, Inc. | Winningham Rick E | CEO, Dir | F - Tax | $8.92 | -37.2K | 1.56M | -2% | -$331.8K | |
| 2023-11-22 | 2023-11-20 | TBPH | Theravance Biopharma, Inc. | Winningham Rick E | CEO, Dir | F - Tax | $10.37 | -15.8K | 1.60M | -1.0% | -$163.9K | |
| 2023-08-22 | 2023-08-20 | TBPH | Theravance Biopharma, Inc. | Winningham Rick E | CEO, Dir | F - Tax | $9.70 | -15.8K | 1.61M | -1.0% | -$153.3K | |
| 2023-08-15 | 2023-08-11 | JAZZ | Jazz Pharmaceuticals plc | Winningham Rick E | Dir | A - Grant | $0.00 | +3,075 | 11.7K | +36% | $0 | |
| 2023-08-15 | 2023-08-14 | JAZZ | Jazz Pharmaceuticals plc | Winningham Rick E | Dir | S - Sale | $138.16 | -1,241 | 10.4K | -11% | -$171.5K | |
| 2023-05-23 | 2023-05-20 | TBPH | Theravance Biopharma, Inc. | Winningham Rick E | CEO, Dir | F - Tax | $11.21 | -15.8K | 1.63M | -1.0% | -$177.2K | |
| 2023-03-03 | 2023-03-01 | TBPH | Theravance Biopharma, Inc. | Winningham Rick E | CEO, Dir | A - Grant | $0.00 | +330.0K | 1.64M | +25% | $0 | |
| 2023-02-22 | 2023-02-20 | TBPH | Theravance Biopharma, Inc. | Winningham Rick E | CEO, Dir | F - Tax | $10.44 | -37.4K | 1.31M | -3% | -$390.7K | |
| 2022-12-16 | 2022-12-14 | TBPH | Theravance Biopharma, Inc. | Winningham Rick E | CEO, Dir | S - Sale | $11.19 | -50.0K | 1.35M | -4% | -$559.5K | |
| 2022-12-16 | 2022-12-13 | TBPH | Theravance Biopharma, Inc. | Winningham Rick E | CEO, Dir | G - Gift | — | -9,000 | 1.40M | -0.6% | — | |
| 2022-11-22 | 2022-11-20 | TBPH | Theravance Biopharma, Inc. | Winningham Rick E | CEO, Dir | F - Tax | $10.85 | -15.8K | 1.41M | -1% | -$171.5K | |
| 2022-08-23 | 2022-08-19 | TBPH | Theravance Biopharma, Inc. | Winningham Rick E | CEO, Dir | F - Tax | $9.34 | -15.8K | 1.42M | -1% | -$147.6K | |
| 2022-08-09 | 2022-08-08 | JAZZ | Jazz Pharmaceuticals plc | Winningham Rick E | Dir | S - Sale | $152.32 | -1,089 | 8,610 | -11% | -$165.9K | |
| 2022-08-09 | 2022-08-05 | JAZZ | Jazz Pharmaceuticals plc | Winningham Rick E | Dir | A - Grant | $0.00 | +2,561 | 9,699 | +36% | $0 | |
| 2022-05-24 | 2022-05-20 | TBPH | Theravance Biopharma, Inc. | Winningham Rick E | CEO, Dir | F - Tax | $8.74 | -11.0K | 1.44M | -0.8% | -$96.4K | |
| D | 2022-03-01 | 2022-02-25 | TBPH | Theravance Biopharma, Inc. | Winningham Rick E | CEO, Dir | A - Grant | $0.00 | +170.0K | 1.45M | +13% | $0 |
| 2022-02-23 | 2022-02-18 | TBPH | Theravance Biopharma, Inc. | Winningham Rick E | CEO, Dir | F - Tax | $9.61 | -22.7K | 1.28M | -2% | -$218.2K | |
| 2021-11-23 | 2021-11-19 | TBPH | Theravance Biopharma, Inc. | Winningham Rick E | CEO, Dir | F - Tax | $8.36 | -11.4K | 1.30M | -0.9% | -$95.3K | |
| 2021-08-24 | 2021-08-20 | TBPH | Theravance Biopharma, Inc. | Winningham Rick E | CEO, Dir | F - Tax | $14.05 | -11.4K | 1.31M | -0.9% | -$160.2K | |
| 2021-08-10 | 2021-08-06 | JAZZ | Jazz Pharmaceuticals plc | Winningham Rick E | Dir | S - Sale | $147.96 | -1,306 | 7,138 | -15% | -$193.2K | |
| 2021-08-02 | 2021-07-29 | JAZZ | Jazz Pharmaceuticals plc | Winningham Rick E | Dir | A - Grant | $0.00 | +2,246 | 8,444 | +36% | $0 |
Purchase Sale Sale after option exercise All abbreviations